Medications

AI use in pharmacotherapy still in the early stages

Detecting drug interactions, discovering new drugs, predicting treatment response, optimizing doses–the list of the potential benefits of artificial intelligence (AI) for pharmacotherapy is long and promising.

Oncology & Cancer

Young adults with cancer at greater risk for HPV-related cancers

A team of researchers at Huntsman Cancer Institute and the University of Utah (the U) found that human papillomavirus-related cancer diagnoses are more common in adolescent and young adults (AYAs) who have previously had ...

page 10 from 27